Article
Mutations upstream of fabI in triclosan resistant Staphylococcus aureus strains are associated with elevated fabI gene expression.
BMC genomics - 30 Apr 2015
Grandgirard Denis, Furi Leonardo, Ciusa Maria Laura, Baldassarri Lucilla, Knight Daniel R, Morrissey Ian, Largiadèr Carlo R, Leib Stephen L, Oggioni Marco R
Abstract excerpt
BACKGROUND: The enoyl-acyl carrier protein (ACP) reductase enzyme (FabI) is the target for a series of antimicrobial agents including novel compounds in clinical trial and the biocide triclosan. Mutations in fabI and heterodiploidy for fabI have been shown to confer resistance in S. aureus strains in a previous study. Here we further determined the fabI upstream sequence of a selection of these strains and the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
